RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.79B
This Quarter Return
+6.53%
1 Year Return
+14.8%
3 Year Return
+52.7%
5 Year Return
+195.9%
10 Year Return
+405.81%
AUM
$763M
AUM Growth
+$763M
(-0.51%)
Cap. Flow
-$48.4M
Cap. Flow
% of AUM
-6.35%
Top 10 Holdings %
Top 10 Hldgs %
34.53%
Holding
214
New
2
Increased
37
Reduced
120
Closed
12
Top Buys
| 1 |
Stryker
SYK
|
$3.31M |
| 2 |
Biogen
BIIB
|
$1.94M |
| 3 |
Gilead Sciences
GILD
|
$1.42M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$1.17M |
| 5 |
CELG
Celgene Corp
CELG
|
$1.09M |
Top Sells
| 1 |
Johnson Controls International
JCI
|
$7.34M |
| 2 |
CVS Health
CVS
|
$5.75M |
| 3 |
Rockwell Automation
ROK
|
$3.62M |
| 4 |
IPG Photonics
IPGP
|
$2.98M |
| 5 |
J.M. Smucker
SJM
|
$2.63M |
Sector Composition
| 1 | Healthcare | 26.83% |
| 2 | Technology | 20.54% |
| 3 | Industrials | 14.4% |
| 4 | Financials | 9.98% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sysco
SYY
$38.5B
| $396K | 0.05% |
6,520
-400
| -6% | -$24.3K |
|
152
Caterpillar
CAT
$196B
| $395K | 0.05% |
2,506
| – | – |
|
|
KSU
153
DELISTED
Kansas City Southern
KSU
| $395K | 0.05% |
3,750
| – | – |
|
154
Air Products & Chemicals
APD
$65.5B
| $389K | 0.05% |
2,370
| – | – |
|
155
Boston Scientific
BSX
$156B
| $383K | 0.05% |
15,467
-425
| -3% | -$10.5K |
|
156
Adient
ADNT
$2.01B
| $378K | 0.05% |
4,797
-2,875
| -37% | -$227K |
|
157
WEC Energy
WEC
$34.3B
| $377K | 0.05% |
5,680
-1,895
| -25% | -$126K |
|
158
Portland General Electric
POR
$4.69B
| $370K | 0.05% |
8,111
-4,345
| -35% | -$198K |
|
159
Colgate-Palmolive
CL
$67.9B
| $367K | 0.05% |
4,865
| – | – |
|
160
Dell
DELL
$82.6B
| $357K | 0.05% |
4,387
-1,052
| -19% | -$85.6K |
|
161
Target
TGT
$43.6B
| $342K | 0.04% |
5,240
-1,241
| -19% | -$81K |
|
162
Vanguard Small-Cap ETF
VB
$66.4B
| $340K | 0.04% |
2,298
| – | – |
|
|
CSRA
163
DELISTED
CSRA Inc.
CSRA
| $327K | 0.04% |
10,930
| – | – |
|
164
Roper Technologies
ROP
$56.6B
| $325K | 0.04% |
1,255
-706
| -36% | -$183K |
|
165
Vanguard Small-Cap Value ETF
VBR
$31.4B
| $321K | 0.04% |
2,421
+153
| +7% | +$20.3K |
|
166
Walmart
WMT
$774B
| $319K | 0.04% |
3,229
+246
| +8% | +$24.3K |
|
167
T Rowe Price
TROW
$23.6B
| $317K | 0.04% |
3,025
| – | – |
|
168
Baxter International
BAX
$12.7B
| $314K | 0.04% |
4,862
-1,850
| -28% | -$119K |
|
169
GSK
GSK
$79.9B
| $309K | 0.04% |
8,709
-3,750
| -30% | -$133K |
|
170
UnitedHealth
UNH
$281B
| $309K | 0.04% |
1,401
| – | – |
|
171
F5
FFIV
$18B
| $306K | 0.04% |
2,331
-293
| -11% | -$38.5K |
|
172
Berkshire Hathaway Class A
BRK.A
$1.09T
| $298K | 0.04% |
1
| – | – |
|
173
Cigna
CI
$80.3B
| $298K | 0.04% |
1,465
| – | – |
|
174
Adobe
ADBE
$151B
| $295K | 0.04% |
1,685
| – | – |
|
175
American Electric Power
AEP
$59.4B
| $273K | 0.04% |
3,711
| – | – |
|